Pioneer Health Systems: Confirmed Subchapter V Plan After Failed Sale

Pioneer Health Systems LLC, operating as Direct Orthopedic Care, filed for chapter 11 protection under Subchapter V in the U.S. Bankruptcy Court for the District of Delaware on February 21, 2024. The company operated full-service orthopedic clinics across Texas and Oklahoma, with 13 locations and approximately 167 full-time employees at the time of filing. Management attributed the filing to an underfunded expansion strategy that added leverage without a clear path to service the resulting debt, compounded by slow closure of unprofitable locations and an inability to keep up with obligations to noteholders, landlords, and trade creditors. The five jointly administered entities included Pioneer Health Systems LLC, DOC LLC, DOC Corporate Group LLC, DOCTX3 PLLC, and PAS Services PLLC.

Over nearly two years, the case moved through multiple DIP financing structures, a confirmed plan, a contested post-confirmation sale process that was twice terminated, a professional fee dispute that reached appeal, and adversary recovery actions that continued into 2026. The court confirmed the Second Amended Subchapter V Plan on December 20, 2024, the plan became effective on May 5, 2025, and the debtors filed a notice of substantial consummation on January 23, 2026. The case remained active through claims objections, the Provident appeal, and newly filed avoidance actions as of early 2026, with claims-objection deadlines extending into at least April 2026.

Debtor(s)	Pioneer Health Systems LLC d/b/a Direct Orthopedic Care (5 jointly administered entities)
Court	U.S. Bankruptcy Court, District of Delaware
Case Number	24-10279
Petition Date	February 21, 2024
Confirmation Date	December 20, 2024
Judge	Hon. J. Kate Stickles
DIP Facility	Initial $700,000 revolving facility from David Hassinger at 15%+ per annum; later restructured through TFGH Ventures and Bonito Kitty

Expansion Strategy and Filing Triggers

CEO Colin Chenault stated in the First Day Declaration that the company raised debt repeatedly to fund an aggressive expansion strategy without matching revenue growth to service the added leverage. The debtors had previously employed as many as 213 full-time employees but had contracted to approximately 167 full-time employees, 47 part-time or PRN employees, and 6 contractors by the petition date. The company had also exited the California market by 2019, leaving operations concentrated in Texas and Oklahoma across 13 clinic locations at the time of filing.

The declaration identified several specific distress drivers: slow closure of unprofitable locations that continued to consume resources, an inability to keep up with noteholder debt service, mounting landlord obligations, and unpaid trade creditors. Chenault framed the filing as a deliberate effort to use chapter 11 to stabilize operations, reject unprofitable leases, reduce debt, and refocus on profitability and cash flow. The stated restructuring objectives made clear that the debtors intended to emerge as a leaner operator rather than liquidate, positioning the case from the outset as a reorganization under Subchapter V rather than a vehicle for asset disposition. That framing would be tested repeatedly as the case evolved through multiple DIP facilities, a confirmed plan, and a post-confirmation sale process that pitted the debtors' reorganization path against acquisition proposals from outside bidders.

The jointly administered affiliates filed under case numbers 24-10280 through 24-10283, with the lead case assigned to Judge J. Kate Stickles. David M. Klauder was appointed Subchapter V trustee on February 22, 2024, one day after the petitions were filed.

Prepetition Debt and Hassinger DIP Facility

The First Day Declaration described approximately $12,035,942 of total debt net of intercompany obligations. That figure consisted of about $598,355 of secured debt and $11,437,587 of unsecured debt. Roughly $9,755,972 of the unsecured total was insider debt, making the capital structure heavily weighted toward obligations owed to parties connected to the debtors' ownership and management. The outsized proportion of insider debt relative to total obligations was a recurring theme throughout the case, surfacing again in Kiron Capital's later allegations that the sale process favored insiders.

Hassinger bridge loan. A prepetition bridge loan from David Hassinger dated February 14, 2024 — one week before the petition date — had about $350,000 of principal outstanding as of the filing, secured by accounts receivable. The bridge loan provided emergency liquidity to fund the filing itself and was later rolled into the DIP facility.

Initial DIP facility. The March 28, 2024 final DIP order authorized a multi-draw revolving facility of up to $700,000, with up to $500,000 available on an interim basis and the balance available after final approval. The March 28, 2024 hearing confirmed the facility carried a rate of at least 15% per annum plus a $10,000 closing fee — expensive terms reflecting the debtors' limited financing options and the lender's insistence on a high return for providing liquidity to a small healthcare operator in chapter 11. The order granted the DIP lender superpriority administrative expense claims and perfected DIP liens on substantially all assets, all subject to a professional fee carve-out. DIP proceeds were authorized to repay the prepetition bridge loan in full. The order also provided adequate protection for the prepetition secured party against any postpetition diminution in value caused by the DIP facility, cash-collateral use, or the priming liens.

Later DIP structures. The case subsequently moved through a term DIP structure with TFGH Ventures and then an amended or assigned revolving DIP structure with Bonito Kitty. Those later facilities remained tied to sale and plan milestones that pushed the debtors toward either completing a transaction or achieving a plan-effective restructuring by early 2025. The milestone pressure embedded in the DIP terms was a critical driver of the case's trajectory, because it forced the debtors to keep the post-confirmation sale process alive even after confirmation and ultimately shaped the conditions under which the plan could go effective. Bonito Kitty's role as DIP lender also made it a participant in the later subordination arrangement that became part of the terminated sale process.

Subchapter V Plan and Disposable Income Commitment

The debtors filed multiple plan iterations before filing the Second Amended Subchapter V Plan on July 5, 2024. The plan called for a $1.2 million exit facility to retire outstanding DIP debt and support post-emergence liquidity. That exit financing was a critical component of the plan architecture because the DIP facilities had to be retired before the plan could become effective, and the debtors needed working capital to sustain clinic operations through the transition.

Class treatment. The plan projected 100% recovery for Class 3 convenience claims, which were to be paid in full. For Class 4 general unsecured creditors, the plan projected $7,224,865 of distributions on $21,472,803 of allowed claims, funded through a disposable income commitment running through February 14, 2030 — a commitment period measured from the petition date, consistent with the Subchapter V disposable income framework. The projected recovery for Class 4 implied a distribution rate of approximately 33.6 cents on the dollar, a meaningful recovery given the debtors' debt load and the proportion of insider claims in the unsecured pool. Because the approximately $9.8 million of insider unsecured debt sat alongside roughly $11.7 million of third-party unsecured claims in Class 4, the insider claims would absorb a significant share of the disposable income distributions — a dynamic that made the plan's acceptance vote and the later sale-process disputes more contentious. Administrative expenses included $125,000 of professional fees and $50,000 of trustee fees to be paid in full under the plan structure.

Confirmation. The confirmation order entered December 20, 2024 found that impaired Classes 1(k), 1(m), and 4 accepted the plan, while the remaining secured, priority, convenience, and equity classes were unimpaired and deemed to accept. The order conditioned the effective date on several prerequisites: entry of a final confirmation order not subject to any stay, execution of all plan implementation documents including exit-facility papers, and either entry of a sale order or filing of a notice terminating the post-confirmation sale process. That last condition was significant because it meant the plan could not go effective until the sale process reached a definitive conclusion — either a closed sale or a formal termination.

The confirmation order also set the professional fee bar date at 90 days after service of the notice of effective date, established a 45-day rejection-claims deadline tied to the notice of effective date or the relevant rejection date, and provided that the Subchapter V trustee would be discharged upon the debtors filing a notice of substantial consummation. The confirmation order's retained jurisdiction provisions covered post-confirmation disputes including fee applications, claims objections, avoidance actions, and interpretation of plan terms — all of which became active in 2025 and 2026. Those retained-jurisdiction provisions proved essential as the case generated contested matters including the Provident fee dispute, ongoing claims reconciliation, and newly filed adversary proceedings well beyond the effective date.

Failed Sale Process and Kiron Capital Dispute

The confirmed plan left room for a post-confirmation asset sale, and the debtors moved quickly to test the market. The sale motion filed January 9, 2025 sought authority to sell substantially all operating assets, excluding cash and certain retained causes of action. The debtors stated that the sale was intended to maximize estate value and preserve employee jobs while satisfying the plan's post-confirmation sale procedures and staying within the DIP-driven timelines that required resolution of the sale question before the plan could go effective.

Kiron Capital's bids and objections. The sale process produced competing bids but no completed transaction. Kiron Capital submitted a baseline $15.75 million bid and later submitted a $22.229 million net-present-value bid. In a February 5, 2025 objection and status-conference motion, Kiron attacked the process as opaque and tilted toward insiders. Kiron specifically alleged that the debtors changed bidding requirements after the submission deadline, relied on new financial projections that had not been shared with bidders, and favored an insider-led recapitalization alternative over Kiron's higher-value proposals. Those allegations echoed earlier governance disputes in the case: MSC Holding and Medport Billing had previously sought removal of the debtors as debtors in possession, and PCD Building Corp. had litigated construction-related claim issues, creating a pattern of creditor distrust around management decision-making and value-maximization.

First termination. The first notice terminating the sale process, filed February 4, 2025 after a two-day auction on February 3-4, stated that the debtors had considered Kiron's proposals alongside a proposed subordination arrangement from Bonito Kitty and certain unsecured claimholders totaling $9,456,330. After consulting with the Subchapter V trustee and professionals, the debtors concluded that executing a sale was not in the best interests of the estates and stakeholders and terminated the process without selecting a prevailing bid. The subordination arrangement was notable because it involved the DIP lender (Bonito Kitty) and unsecured claimholders agreeing to restructure their claims rather than support a third-party acquisition — effectively choosing continued ownership under the confirmed plan over a sale to an outside buyer.

Second auction and final termination. The sale fight did not end with the first termination. The docket reflected reopened or supplemental disputes, another auction round in March 2025, and ultimately a second notice of termination of the sale process on April 25, 2025. That sequence was important because the confirmation order had conditioned the plan's effective date on either closing a sale or formally terminating the process. The second termination finally cleared the last prerequisite, and the plan went effective on May 5, 2025 — more than four months after confirmation.

Provident Fee Dispute

Provident Healthcare Partners was retained as investment banker during the post-confirmation sale process to market the debtors' assets and manage the auction. After the sale process was terminated without a closing, Provident sought a $500,000 transaction fee. The reorganized debtors objected, arguing that Provident's engagement letter and the court's retention order made the fee contingent on a completed sale or comparable transaction. The debtors said the plan-effective restructuring and the related subordination arrangement did not satisfy that contractual trigger because no assets were actually sold and no purchase price was paid.

At the November 21, 2025 hearing, the court focused on whether any qualifying transaction had actually closed. The transcript reflects the court's conclusion that the governing documents unambiguously tied Provident's fee to a sale-type transaction — specifically, a sale or transfer of property for a price — and that the ultimate resolution of the case, including the subordination arrangement, did not meet that standard. The court drew a clear distinction between a plan-effective restructuring in which existing stakeholders realigned their claims and a sale in which assets changed hands for consideration.

The order denying Provident's fee application, entered December 8, 2025, sustained the reorganized debtors' objection in full for the reasons stated on the record at the hearing. Provident then appealed the ruling, and the record on appeal was transmitted to the district court in late December 2025. The appeal remained pending as of early 2026 and represents one of the case's open post-confirmation threads.

Post-Effective Claims and Avoidance Actions

The debtors filed their notice of effective date on May 5, 2025. That notice set June 20, 2025 as the administrative-expense bar date, August 4, 2025 as the professional fee bar date, and a 45-day deadline for rejection-damage claims measured from service of the notice or the relevant rejection date.

Professional fee awards. The case generated significant professional-fee activity. The Subchapter V trustee's first interim fee application covered February 22, 2024 through December 31, 2024 and sought $23,217.50 in fees with no expenses, with the largest work buckets being plan and disclosure-statement work, hearings, and case administration. Klauder's final trustee award totaled $54,872.50 plus $39.50 of expenses, reflecting the trustee's continued involvement through the sale process termination and plan effective date. Dorsey & Whitney, serving as debtors' counsel, received a final award of $2,198,016.90, a substantial figure that reflected the case's complexity and duration — spanning multiple DIP structures, plan amendments, a contested sale process, and post-confirmation implementation.

Substantial consummation. The notice of substantial consummation filed January 23, 2026 stated that the plan had been substantially consummated through property transfers, assumption of plan-property management, and the commencement of distributions to creditors. That filing also triggered discharge of the Subchapter V trustee under the confirmed plan's terms, ending Klauder's oversight role.

Claims reconciliation. Claims administration remained active well into 2026. On January 27, 2026, the court approved a stipulation allowing Kalidy LLC a Class 4 general unsecured claim of $389,136.14. On March 3, 2026, the court extended the claims-objection deadline through April 6, 2026, finding just cause for the extension and concluding that continued time to reconcile claims served the interests of the estates and parties in interest.

Avoidance actions. The reorganized debtors also began filing adversary recovery actions on February 20, 2026. One complaint, filed against Mid-America Apartments, L.P., seeks to avoid and recover preferential transfers from the 90 days before the petition date, pursue fraudulent-transfer theories subject to proof, and disallow any claims the defendant may hold under section 502 of the Bankruptcy Code. The complaint also sought to disallow any claims the defendant may hold under section 502, which would reduce the pool of allowed claims competing for plan distributions. The avoidance actions represent a potentially significant source of additional recoveries for the estates and are an important component of the ongoing post-effective administration, alongside the claims-objection process that continued with the court's approval of the April 6, 2026 extension.

Key Case Timeline

Date	Event
Feb. 21, 2024	Chapter 11 petitions filed under Subchapter V
Feb. 22, 2024	David M. Klauder appointed Subchapter V trustee
Mar. 28, 2024	Final order entered on initial DIP facility
Jul. 5, 2024	Second Amended Subchapter V Plan filed
Dec. 20, 2024	Confirmation order entered
Jan. 9, 2025	Post-confirmation sale motion filed
Feb. 3-4, 2025	Two-day auction held; no prevailing bid selected
Feb. 4, 2025	First notice terminating sale process
Feb. 5, 2025	Kiron Capital objected to sale process
Mar. 2025	Second auction round held
Apr. 25, 2025	Second notice terminating sale process
May 5, 2025	Plan effective date
Nov. 21, 2025	Hearing on Provident fee application
Dec. 8, 2025	Provident fee application denied
Jan. 23, 2026	Notice of substantial consummation filed; trustee discharged
Jan. 27, 2026	Kalidy LLC claim stipulation approved
Feb. 20, 2026	Adversary avoidance actions commenced
Mar. 3, 2026	Claims-objection deadline extended to Apr. 6, 2026

Frequently Asked Questions

What type of bankruptcy did Pioneer Health Systems file?

Pioneer Health Systems LLC filed for chapter 11 protection under Subchapter V, a streamlined reorganization framework for small business debtors, in the U.S. Bankruptcy Court for the District of Delaware on February 21, 2024. The five jointly administered entities operated full-service orthopedic clinics under the Direct Orthopedic Care brand.

Was the Pioneer Health Systems reorganization plan confirmed?

The court confirmed the Second Amended Subchapter V Plan on December 20, 2024. The plan became effective on May 5, 2025 after the post-confirmation sale process was terminated, and the debtors filed a notice of substantial consummation on January 23, 2026.

What happened to the post-confirmation sale process?

The debtors twice terminated the sale process without selecting a prevailing bid. Kiron Capital, which submitted bids valued at up to $22.2 million, alleged the process was opaque and favored insiders. The first termination followed a February 2025 auction, and the second termination on April 25, 2025 cleared the path for the plan to go effective.

What are the projected recoveries for unsecured creditors?

The confirmed plan projected $7.2 million of distributions on approximately $21.5 million of Class 4 general unsecured claims, implying a recovery rate of approximately 33.6 cents on the dollar. Distributions are funded through a disposable income commitment running through February 14, 2030.

What is the status of the Provident Healthcare Partners fee dispute?

The court denied Provident's $500,000 transaction fee request in full on December 8, 2025, finding that no qualifying sale transaction had closed and that the governing documents unambiguously required a sale-type event. Provident appealed the ruling, and the appeal remained pending as of early 2026.

For more bankruptcy case coverage, visit the ElevenFlo bankruptcy blog.